RXRX - Recursion Hosts Second Annual Rare Disease Day Events for Utah's Rare Disease Community | Benzinga
SALT LAKE CITY, March 01, 2024 (GLOBE NEWSWIRE) -- Recursion (NASDAQ:RXRX), a leading clinical stage TechBio company decoding biology to industrialize drug discovery, hosted its second annual Rare Disease Day event at its headquarters on February 29 and virtually in partnership with Alliance to Cure at eight sites across the United States to provide resources and support for Utah's rare disease community. The event featured speakers from patient advocacy organizations and biotech and healthcare industry leaders who all share a goal to accelerate the diagnosis and improve the care of more than 344,000 Utahns living with a rare disease.
In the United States, a rare disease is considered a condition with less than 200,000 patients. More than 10,000 rare diseases are known, most of which are genetic in nature. An estimated one in 10 people in the United States have a rare disease. Today, 95 percent of rare diseases have no treatment.
Recursion's Rare Disease Day event was intended to raise awareness for rare and undiagnosed diseases and the lifelong impact they have on patients and their families – while highlighting progress in diagnosis and treatment discovery. The event recognized advocates who have been instrumental in building Utah's rare disease community and have dedicated themselves to support this important work.
"This event serves as an important reminder of the strength, resilience and unrelenting spirit of our rare ...